7,8-Dihydroxy-4-phenylcoumarin

CAS No. 842-01-3

7,8-Dihydroxy-4-phenylcoumarin( —— )

Catalog No. M19166 CAS No. 842-01-3

7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
5MG 36 In Stock
10MG 48 In Stock
25MG 68 In Stock
50MG 86 In Stock
100MG 119 In Stock
200MG Get Quote In Stock
500MG 303 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7,8-Dihydroxy-4-phenylcoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase
  • Description
    7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    842-01-3
  • Formula Weight
    254.24
  • Molecular Formula
    C15H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (393.33 mM)
  • SMILES
    C1=CC=C(C=C1)C2=CC(=O)OC3=C2C=CC(=C3O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • UFP-101

    Potent, selective and competitive silent antagonist for the NOP opioid receptor. Binds to NOP with high affinity (pKi = 10.24) and displays > 3000-fold selectivity over δ, μ and κ opioid receptors. Antinociceptive and opposes the action of nociceptin in vivo.

  • BPR1M97

    BPR1M97 is a mu opioid receptor (MOP) and neuropeptide-orphin FQ (NOP) receptor agonist with blood-brain barrier permeability and potency.

  • (-)-U-50488 hydrochl...

    The more active enantiomer of (±)-U-50488, a potent, selective kappa-opioid receptor agonist with no μ-opioid antagonist effects.